HRCT evaluation has been demonstrated useful in predicting the presence of anti‐MDA5 antibody in DM‐ILD23; however, the prognostic value of HRCT manifestations for MDA5‐DM/CADM‐ILD has not been fully evaluated. The gene discussed is IFIH1; the disease is clinically amyopathic dermatomyositis.